As interest in Latin America’s medical marijuana industry grows, a major stock exchange in Canada could soon see the first listings from companies with their core operations in Colombia.
Khiron Life Sciences CEO Alvaro F. Torres told Marijuana Business Daily the company expects to complete the regulatory paperwork in time to start trading as early as next week on the TSX Venture Exchange under the ticker symbol KHRN.
“This is a major milestone for us and the country, because this means the (TSX Venture Exchange) has also validated the Colombian regulatory system and found it satisfactory,” Torres said. “I know we are breaking ground for many more companies to list and this is a proud achievement.”
Khiron is among a number of Latin American medical marijuana companies with their core business in Colombia and head office in Toronto to tap